Q1 2014 · —
Revenue$215.06M$215.06M +9.4% vs Q1 2013−2.6% vs Q4 2013
Net Income$2.21M$2.21M N/M vs Q1 2013−84.0% vs Q4 2013
EPS Diluted$0.07$0.07 N/M vs Q1 2013−84.4% vs Q4 2013
Gross Profit$112,556,000−3.8%
Operating Income$8,738,000N/M
Operating Cash Flow$11,254,000+43.4%
Free Cash Flowderived-$81,000N/M
Margins · derived
Gross margin52.3%−7.2 pt vs Q1 2013
Operating margin4.1%+5.2 pt vs Q1 2013
Net margin1.0%+4.1 pt vs Q1 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $215.06M | $196.65M | $196.19M | $181.04M |
| Net Income | $2.21M | -$6.03M | $6.69M | $11.49M |
| EPS Diluted | $0.07 | -$0.22 | $0.23 | $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR